Published in:
01-08-2015 | Astute Clinician Report
Potentially Beneficial Effect of Hydroxychloroquine in a Patient with a Novel Mutation in Protein Kinase Cδ Deficiency
Authors:
Ayca Kiykim, Ismail Ogulur, Safa Baris, Elisabeth Salzer, Elif Karakoc-Aydiner, Ahmet Oguzhan Ozen, Wojciech Garncarz, Tatjana Hirschmugl, Ana Krolo, Ayse Deniz Yucelten, Kaan Boztug, Isil B Barlan
Published in:
Journal of Clinical Immunology
|
Issue 6/2015
Login to get access
Abstract
Protein kinase C delta (PRKCD) has essential functions in controlling B-cell proliferation and apoptosis, development of B-cell tolerance and NK-cell cytolitic activity. Human PRKCD deficiency was recently identified to be causative for an autoimmune lymphoproliferative syndrome like disorder with significant B-cell proliferation particularly of immature B cells. Here we report a child with a novel mutation in PRKCD gene who presented with CMV infection and an early onset SLE-like disorder which was successfully treated with hydroxychloroquine.